Financial Disclosure I have the following financial interests or - - PowerPoint PPT Presentation

▶

Sep 24, 2023 20 likes •72 views

12/2/2016 Financial Disclosure I have the following financial interests or relationships to disclose: Alcon Laboratories, Inc.: Consultant/Advisor Allergan, Inc.: Consultant/Advisor, Grant Support Current Approaches to Scleral ThromboGenics:

SLIDE 1

12/2/2016 1

Current Approaches to Scleral PCIOL Fixation

George A. Williams, M.D. Ashkan M. Abbey, M.D. Oakland University William Beaumont School of Medicine Beaumont Health Royal Oak, MI

Financial Disclosure

I have the following financial interests or relationships to disclose: Alcon Laboratories, Inc.: Consultant/Advisor Allergan, Inc.: Consultant/Advisor, Grant Support ThromboGenics: Equity Owner ForSight: Consultant/Advisor, Equity Owner Johnson & Johnson: Consultant/Advisor OMIC-Ophthalmic Mutual Insurance Company: Employee OptiMedica: Consultant/Advisor, Equity Owner Retrosense: Consultant/Advisor, Equity Owner Vitamin Health: Consultant/Advisor Covalent Medical: Equity Owner

Dislocated PCIOL

SLIDE 2

12/2/2016 2

Scleral Fixation Scleral Fixation

Prenner et al, Retina 2012;32:853-855

Scleral Fixation

Prasad S, Retina 2013; 33: 657-660

SLIDE 3

12/2/2016 3

SLIDE 4

12/2/2016 4

Anterior Segment OCT Ultrasound Biomicroscopy

SLIDE 5

12/2/2016 5

Wills Group Jon Prenner Conclusions

Scleral fixation of PCIOLs using trocar cannulas, scleral tunnels or suture suspension is an effective surgical option for the treatment of aphakia or IOL dislocation.